Type 1 Diabetes Treatment

|

29

Diabetes Treatment Targets Have Not Improved in Over Two Decades

Advances in diabetes care over the past two decades have not effectively improved diabetes outcomes for American adults, in particular young, female …

|

Children that Have Access to CGMs Have Improved Diabetes Care

Although the use of continuous glucose monitors (CGMs) in clinical practice has drastically increased over the past five to six years, only about 25% …

|

Drug Targeting Immune System Delays Type 1 Diabetes in High Risk Patients

A drug that targets the immune system can delay the onset of Type 1 diabetes an average of two years in children and adults at high risk, according …

Health Coaches; Incentives Help Children with Type 1 Diabetes Improve Glycemic Control

Tom Manatos and Dana Edwards Manatos‘ 8-year-old son, Andrew Manatos, was diagnosed with Type 1 diabetes just a few days after his 7th …

|

Study Finds Holidays Disrupt Drug Routines of Children with Diabetes

New research from Australia finds children with Type 1 diabetes find it difficult to adhere to their drug routines during school holidays and …

“Smart” Insulin Could Prevent Hypoglycemia During Diabetes Treatment

Bioengineers at the University of California, Los Angeles have developed a new type of insulin that could help prevent hypoglycemia in people who use …

| | |

Research: Finding Innovative Ways to Predict Autoimmunity in Type 1 Diabetes

Finding a reliable indicator to predict the onset of autoimmunity in Type 1 diabetes has eluded scientists for many years. As a result, Type 1 …

|

Special Spotlight On Diabetes Insulins: Soliqua 100/33 (insulin glargine/lixisenatide)

Medically reviewed by Lindsay Slowiczek, PharmD on April 5, 2019. Written by Victor Nguyen, PharmD, MS. Republished with permission from Healthline. …

|

Researchers Seek to Understand Pancreas Formation to Aid Type 1 Diabetes Treatments

Researchers have discovered a key clue into the development of the pancreas and brain by studying rare patients born without a pancreas. The study …

|

Provention Bio Initiates Pivotal Study in Patients with Recent Onset Type 1 Diabetes

Provention Bio, Inc., a clinical-stage company dedicated to intercepting and preventing immune-mediated diseases, today announced that it has dosed …

|